Dr. Mason attended the European Molecular Imaging Meeting in Porto, Portugal, in March, where he gave an oral presentation regarding development of the vascular disrupting agent OXi8007 and imaging the pathophysiological sequalae in orthotopic kidney tumors in mice (“Multimodal imaging (Bioluminescence, Multispectral Optoacoustic, and Doppler Ultrasound) to assess efficacy of vascular disrupting agent (OXi8007): potential long-term benefits in combination treatment for pre-clinical orthotopic kidney tumor models” on behalf of the team Hashini Wanniarachchi, Lorena. Bueno, Ricardo Rayas, Jackson Bell, Hans Hammers, Q. Zhang, Li Liu in collaboration with colleagues Khagendra Hamal, Cyprian Pavlich, Christian Borchardt, Mary Lynn Trawick, Kevin Pinney at Baylor University).
He also presented a poster regarding our ongoing investigations of peripheral artery diseases (“Imaging peripheral artery disease (PAD) in mice using multi-spectral optoacoustic tomography (MSOT)” on behalf of the team Bushra Afzal, Hashini Wanniarachchi, Tam Nguyen, E. Gerhard, Y. Su, Jian Yang, Kytai Nguyen representing the ongoing collaboration with researchers at UT Arlington and Penn State University.). Dr. Mason then had the pleasure of visiting the small animal imaging resource at the University of Liverpool, hosted by Professor Harish Poptani, where he gave a lecture entitled “Multi-modal imaging for development of biomarkers for assessing tumour oxygenation, blood flow, and response to treatment” to the Institute of Systems, Molecular and Integrative Biology. He then visited Professor Sarah Bohndiek at CRUK in Cambridge, where he gave a seminar “Imaging tumor vasculature and oxygenation for effective therapy”